350 related articles for article (PubMed ID: 23577876)
1. Advantages of a subcutaneous implantable cardioverter-defibrillator in LAMP2 hypertrophic cardiomyopathy.
Zaki A; Zaidi A; Newman WG; Garratt CJ
J Cardiovasc Electrophysiol; 2013 Sep; 24(9):1051-3. PubMed ID: 23577876
[TBL] [Abstract][Full Text] [Related]
2. Arrhythmias and fasciculoventricular pathways in patients with Danon disease: A single center experience.
Jhaveri S; Herber J; Zahka K; Boyle GJ; Saarel EV; Aziz PF
J Cardiovasc Electrophysiol; 2019 Oct; 30(10):1932-1938. PubMed ID: 31240821
[TBL] [Abstract][Full Text] [Related]
3. Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience.
Weinstock J; Bader YH; Maron MS; Rowin EJ; Link MS
J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26873684
[TBL] [Abstract][Full Text] [Related]
4. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
[TBL] [Abstract][Full Text] [Related]
5. Eligibility for the Subcutaneous Implantable Cardioverter-Defibrillator in Patients With Hypertrophic Cardiomyopathy.
Francia P; Adduci C; Palano F; Semprini L; Serdoz A; Montesanti D; Santini D; Musumeci B; Salvati A; Volpe M; Autore C
J Cardiovasc Electrophysiol; 2015 Aug; 26(8):893-899. PubMed ID: 25996259
[TBL] [Abstract][Full Text] [Related]
6. Asymptomatic young man with Danon disease.
Kim J; Parikh P; Mahboob M; Arrighi JA; Atalay MK; Rowin EJ; Maron MS
Tex Heart Inst J; 2014 Jun; 41(3):332-4. PubMed ID: 24955057
[TBL] [Abstract][Full Text] [Related]
7. Clinical utility of genetic testing in the early diagnosis of Danon disease mimicking hypertrophic cardiomyopathy: a case report.
Novelli V; Bisignani A; Pelargonio G; Primiano G; Narducci ML; Palmieri V; Tiziano FD; Zeppilli P; Servidei S; Crea F; Genuardi M
BMC Cardiovasc Disord; 2020 Apr; 20(1):156. PubMed ID: 32248794
[TBL] [Abstract][Full Text] [Related]
8. Clinical impact of nonsustained ventricular tachycardia recorded by the implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy.
Francia P; Santini D; Musumeci B; Semprini L; Adduci C; Pagannone E; Proietti G; Volpe M; Autore C
J Cardiovasc Electrophysiol; 2014 Nov; 25(11):1180-7. PubMed ID: 25066044
[TBL] [Abstract][Full Text] [Related]
9. A young patient with Danon disease receives two ICD shocks: why?
Zannad N; Pierre B; Cosnay P; Babuty D
Pacing Clin Electrophysiol; 2010 May; 33(5):618-9. PubMed ID: 20230469
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of subcutaneous implantable cardioverter-defibrillator testing in patients with hypertrophic cardiomyopathy.
Maurizi N; Tanini I; Olivotto I; Amendola E; Limongelli G; Losi MA; Allocca G; Perego GB; Pieragnoli P; Ricciardi G; De Filippo P; Ferrari P; Quarta G; Viani S; Rapacciuolo A; Bongiorni MG; Cecchi F
Int J Cardiol; 2017 Mar; 231():115-119. PubMed ID: 28073660
[TBL] [Abstract][Full Text] [Related]
11. Identification of LAMP2 Mutations in Early-Onset Danon Disease With Hypertrophic Cardiomyopathy by Targeted Next-Generation Sequencing.
Fu L; Luo S; Cai S; Hong W; Guo Y; Wu J; Liu T; Zhao C; Li F; Huang H; Huang M; Wang J
Am J Cardiol; 2016 Sep; 118(6):888-894. PubMed ID: 27460667
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.
Maron BJ; Shen WK; Link MS; Epstein AE; Almquist AK; Daubert JP; Bardy GH; Favale S; Rea RF; Boriani G; Estes NA; Spirito P
N Engl J Med; 2000 Feb; 342(6):365-73. PubMed ID: 10666426
[TBL] [Abstract][Full Text] [Related]
13. Subcutaneous versus transvenous implantable defibrillator in patients with hypertrophic cardiomyopathy.
Jankelson L; Garber L; Sherrid M; Massera D; Jones P; Barbhaiya C; Holmes D; Knotts R; Bernstein S; Spinelli M; Park D; Aizer A; Chinitz L
Heart Rhythm; 2022 May; 19(5):759-767. PubMed ID: 35038570
[TBL] [Abstract][Full Text] [Related]
14. Danon disease due to a novel splice mutation in the LAMP2 gene.
Nadeau A; Therrien C; Karpati G; Sinnreich M
Muscle Nerve; 2008 Mar; 37(3):338-42. PubMed ID: 18004770
[TBL] [Abstract][Full Text] [Related]
15. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].
Marín F; Gimeno JR; Payá E; García-Alberola A; Pérez-Alvarez L; Fernández X; de la Morena G; Sogorb F; Castro-Beiras A; Valdés M; Martínez JG; Monserrat L
Rev Esp Cardiol; 2006 Jun; 59(6):537-44. PubMed ID: 16790196
[TBL] [Abstract][Full Text] [Related]
16. Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy.
Maron BJ; Spirito P; Ackerman MJ; Casey SA; Semsarian C; Estes NA; Shannon KM; Ashley EA; Day SM; Pacileo G; Formisano F; Devoto E; Anastasakis A; Bos JM; Woo A; Autore C; Pass RH; Boriani G; Garberich RF; Almquist AK; Russell MW; Boni L; Berger S; Maron MS; Link MS
J Am Coll Cardiol; 2013 Apr; 61(14):1527-35. PubMed ID: 23500286
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of subcutaneous implantable cardioverter-defibrillator candidacy based on template ECG screening in patients with hypertrophic cardiomyopathy.
Maurizi N; Olivotto I; Olde Nordkamp LR; Baldini K; Fumagalli C; Brouwer TF; Knops RE; Cecchi F
Heart Rhythm; 2016 Feb; 13(2):457-63. PubMed ID: 26362577
[TBL] [Abstract][Full Text] [Related]
18. Danon disease presenting with early onset of hypertrophic cardiomyopathy and peripheral pigmentary retinal dystrophy in a female with a
Meinert M; Englund E; Hedberg-Oldfors C; Oldfors A; Kornhall B; Lundin C; Wittström E
Ophthalmic Genet; 2019 Jun; 40(3):227-236. PubMed ID: 31264915
[No Abstract] [Full Text] [Related]
19. Ventricular Fibrillation Refractory to Cutaneous Electrical Defibrillation in a Morbidly Obese Pediatric Patient With Hypertrophic Cardiomyopathy: A Case Report.
Gylys MH; Rajan G
A A Pract; 2019 Sep; 13(6):201-203. PubMed ID: 31008723
[TBL] [Abstract][Full Text] [Related]
20. A rare phenotype of heterozygous Danon disease mimicking apical hypertrophic cardiomyopathy.
Yu L; Wan K; Han Y; Chen Y
Eur Heart J; 2018 Sep; 39(34):3263-3264. PubMed ID: 29240871
[No Abstract] [Full Text] [Related]
[Next] [New Search]
